METHODS
This was a cross-sectional observational study on individuals diagnosed with RA and controls. It used a convenience sample that included all consecutive RA patients who went for consultations between July 2015 and February 2017 in the same university hospital. They were included in the study in the order of their appointments, according to their willingness to participate in the study.
For subjects to be included in the patient group, they needed to have reached a score of at least six points in the 2010 classification criteria of the American College of Rheumatology (ACR)/ European League Against Rheumatism (EULAR). 6 For subjects to be included in the control group, they needed to be free from chronic inflammatory disease, orthopedic or neuromuscular disease, or any other condition affecting foot health; and to have come for consultation at the dermatology clinic for cosmetic reasons.
Controls were matched with RA patients for age, gender and body mass index (BMI).
Approval for this study was granted by the local research ethics committee (date: May 11, 2016 The FFI-BR questionnaire is divided into three domains: disability, difficulty and pain. The responses are given on a numerical scale, from 0 to 10. The total score is obtained for each patient as the arithmetic mean of the three domains and is multiplied by 100 to obtain a percentage. Higher scores mean that foot health is worse and, consequently, so is the individual's quality of life.
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The FHSQ-BR questionnaire also presents three domains.
The first assesses foot health in four sections: foot pain, foot func- The calculations were done with the help of the GraphPad Prism software, version 5.0.
RESULTS a) Description of study sample
In the study period, 200 participants were included, 100 in each group. The pairing of the RA patients and controls and the epidemiological data on these subjects are shown in Table 1 . The median duration of the disease among the sample of RA patients was 9.5 years (range: 1 to 54 years). Among these patients, 56.3% were positive for RF and 32% were positive for ANA.
The median DAS-28-ESR score was 3. a range from one to 105 mm; and the median CRP concentration was 6 mg/dl, with a range from 0.1 to 54 mg/dl.
The treatment profile showed that 18% of the RA patients were treated with antimalarial drugs, 72% with methotrexate, 42% with leflunomide, 31% with anti-TNFα and 1% with other biological drugs.
b) Comparison of FFI-BR and FHSQ-BR results between RA patients and controls
The comparison between the scores of RA patients and controls, from the FFI-BR and FHSQ-BR instruments, is shown in Table 2 . This table shows that the RA patients presented worse foot function in all the domains studied, in both questionnaires.
c) Correlation between foot function and RA variables
The correlations relating to both questionnaires are shown in Table 3 . These showed that all the domains of the FFI-BR correlated with the disease activity measured using DAS-28-ESR. This correlation was also shown for all FHSQ-BR domains except for the patient's social capacity and use of shoes.
It was also found that the total score of the FFI-BR questionnaire did not have any association with body mass index (BMI) (P = 0.17), presence of RF (P = 0.49) or presence of ANA (P = 0.30).
There was no association between the domains of the FHSQ-BR and the presence of RF and ANA (P = 0.49 and 0.30 respectively).
BMI showed a modest correlation with foot pain (Spearman rho = -0.24; 95% CI = -0.45 to -0.04; P = 0.01), but this was unrelated to the other domains studied, for which P was non-significant in all cases.
DISCUSSION
In this study, foot dysfunction evaluated using the FFI-BR questionnaire was higher in the RA group than in the control group. Dysfunction and pain generate disability, which in this study was also higher among the patients than among the controls. A similar trend was found regarding foot function measured using the FHSQ-BR questionnaire. Although impaired, the function of our patients' feet proved to be better than was seen in Ferreira's sample, 9 among patients from a reference outpatient clinic in São
Paulo. In that study, the score was 48, while in the current study it was 68.7. 9 Use of new drugs for treating RA and more aggressive treatment strategies that enable better control over the inflammatory activity of RA may explain this difference.
Impairment of RA patients' motor capacity can compromise their lifestyle, through mechanical difficulties and insecurity, thereby depriving them of their daily activities, social living and ability to access different places. 10 Additionally, this impairment leads to increasing dependence on family support and consequent frustration and anger, which promote social isolation, emotional instability and depression. 11 Anxiety and depression are associated with reduced physical activity and sedentary lifestyle, and thus their presence ends up worsening these individuals' general health in the long run. 12, 13 This was reflected, in our study, in the social capacity assessed through the FHSQ-BR questionnaire, which showed worse scores in the group of patients than among the controls.
In comparison with Ferreira's sample, our patients had better results regarding sociability, thus showing that those with worse foot health also had worse social performance. 9 In evaluating the shoes domain of the FHSQ-BR questionnaire, RA patients reported that they had twice as much difficulty in finding adequate shoes, compared with the control group, and that they could not use all types of shoes. The complaints about shoes were even worse in Ferreira's sample, in which the patients scored 5.8, i.e. around five times lower than in the present study. 9 This difference may have been related to fewer footwear options at that time or to less knowledge about the subject.
Some of the difficulties found by RA patients regarding shoes probably resulted from the fact that the shoe industry focuses on esthetics rather than comfort and functionality, thus leaving the population with special needs without any choice. The alternative is to search for orthopedic shoes and insoles that are customized for patients, even though their cost is much higher than that of ordinary shoes. Moreover, the greatest challenge in relation to adherence to orthopedic shoes is patients' own resistance to them, due to their unattractive appearance. 14 Many RA patients find it difficult to tie shoe laces because of hand deformities: for these individuals, footwear with Velcro fastenings or elastic openings are options of greater interest. Non-slip soles can also help in fall prevention. In addition, feet also have esthetic importance; deformities may contribute towards greater personal dissatisfaction, especially among women, who are more affected by this rheumatic disease.
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It was evident from both questionnaires in our study that disease activity, as evaluated using DAS-28-ESR, affected foot health.
Thus, strict control over disease activity is a way to avoid loss of foot function, and this needs to be implemented from the time of the initial diagnosis.
Body mass index (BMI) usually affects foot function. An excess of mechanical loading on the knee, ankle and foot joints worsens local pain. 15 Additionally, obese patients' response to treatment is worse, with lower likelihood of remission from the disease. 16 Therefore, stimulating weight loss among obese or overweight patients contributes towards their physical and emotional wellbeing and demonstrates care for the patient's health as a whole. 16 Interestingly, in our study, only the pain assessed according to the FHSQ-BR questionnaire correlated with the BMI value. One possible hypothesis for explaining this is that the degree of inflammation had such an important influence that it caused foot dysfunction even in individuals with low BMI.
This study had limitations and may not have accurately represented patients with RA in general because it was conducted in an outpatient clinic at a tertiary-care hospital, where patients have access to specialized and effective treatment. Greater severity of disease due to uncontrolled disease activity may be seen outside this sample. The Health Assessment Questionnaire (HAQ), an instrument that is used to study functional status in rheumatic diseases, 17 was not used in the present analysis and this was therefore a limitation of this study. Another limitation was the subjectivity of the questionnaires, since ascertaining the dimensions of patients' pain depended directly on the patients' understanding of the questions and on their capacity to understand scales.
Negligence of the impact of foot health on patients' quality of life occurs because feet dysfunction is often interpreted as being natural to the aging process and to the disease. This leads to omission of treatment and delays to it, in this segment of the body. 13 A holistic approach with multidisciplinary treatment, social support and public health policies combating architectural barriers may help RA patients to ensure their autonomy and ability to function as citizens through ensuring their mobility and independence.
CONCLUSION
We concluded that patients with RA had worse scores in the 
